Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > November 2011 - Volume 19 - Issue 6 > Community-Acquired Methicillin-Resistant Staphylococcus Aure...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e3182294bae
Review Articles

Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Brain Abscess: A Case Report and Review of Literature

Nog, Rajat MD*; Badshah, Cyrus MD, PhD†

Collapse Box

Abstract

A 64-year-old man was admitted with new-onset seizures. His examination was normal with no neurological deficits. Computed tomography of the brain showed a hypodense left parietal lobe lesion, but he insisted on early discharge. He was readmitted 12 days later with recurrent seizures. Brain imaging showed significant increase in size of brain mass. Emergent surgery revealed an abscess, which subsequently grew methicillin-resistant Staphylococcus aureus (MRSA). The patient was treated postoperatively with intravenous vancomycin for 8 weeks.

The patient had no risk factors for hospital-acquired infection but recalled having a furuncle 6 weeks before presentation. The diagnosis of community-acquired MRSA abscess was made epidemiologically and on antibiotic sensitivity profile.

Community-acquired MRSA infections are becoming increasingly prevalent with ever-increasing spectrum of invasive presentations. Only 4 cases of Community-acquired MRSA brain abscess have been previously reported, of which 3 had fatal outcomes. In contrast, our patient had complete recovery. A reappraisal of current treatment guidelines for community-acquired brain abscesses, which do not include vancomycin for empiric coverage of MRSA, should be considered.

© 2011 Lippincott Williams & Wilkins, Inc.

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.